LIC hikes stake in Bank of India to 8.38%
Life Insurance Corporation (LIC) has hiked its stake in Bank of India (BoI) to 8.38% as of May 9.
LIC has bought about 2.026% stake in public sector BoI between September 2, 2021, and May 9, 2025, BoI said in a stock exchange disclosure on Tuesday (May 13, 2025).
Also Read | LIC pares stake in NMDC from 7.6% to 5.59%
LIC's stake in the bank has increased from 6.35% to 8.38% over the four-year period.
Shares of Bank of India closed at ₹112.55, up 2.27% over the previous close on the BSE.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Print
18 minutes ago
- The Print
Sensex, Nifty rebound nearly 1 pc on value buying, global share rally
The 50-share NSE Nifty climbed 227.90 points or 0.92 per cent to 24,946.50. The 30-share BSE Sensex jumped 677.55 points or 0.84 per cent to settle at 81,796.15 with 27 of its constituents ending in the green and three with losses. During the day, it surged 747.22 points or 0.92 per cent to 81,865.82. Mumbai, Jun 16 (PTI) Shrugging off geopolitical concerns amid escalating tensions between Israel and Iran, stock markets rebounded by nearly 1 per cent on Monday following value buying in oil & gas and IT shares and gains in other Asian markets as Brent crude oil prices dropped. Among Sensex firms, UltraTech Cement rose the most by 2.39 per cent. Tech Mahindra, HCL Tech, Tata Consultancy Services, Eternal, Asian Paints, Tata Steel and Kotak Mahindra Bank were among the gainers. Tata Motors, Adani Ports and Sun Pharma were the laggards. 'Despite ongoing geopolitical tensions between Israel and Iran, the market moved higher, supported by gains in large-cap stocks, as investors maintained their focus on long-term fundamentals in the time of volatile situations. Geopolitical developments in the Middle East are likely to influence near-term market sentiment, with any signs of de-escalation being closely monitored,' Vinod Nair, Head of Research, Geojit Investments Limited, said. 'Among sectors, oil and gas recorded strong gains, while the IT sector outperformed in anticipation of the upcoming US Fed policy meeting, which is expected to provide further clarity on the interest rate outlook,' Nair added. The BSE midcap gauge jumped 0.93 per cent and smallcap index climbed 0.38 per cent. All BSE sectoral indices ended higher. IT jumped 1.50 per cent, followed by BSE Focused IT (1.50 per cent), teck (1.35 per cent), oil & gas (1.22 per cent), realty (1.21 per cent), services (1.10 per cent) and consumer durables (1.05 per cent). In Asian markets, South Korea's Kospi, Japan's Nikkei 225 index, Shanghai's SSE Composite index and Hong Kong's Hang Seng settled in the positive territory. European markets were quoting in the green. US markets ended lower on Friday. Global oil benchmark Brent crude declined 0.81 per cent to USD 73.63 a barrel. Wholesale price inflation (WPI) declined to a 14-month low of 0.39 per cent in May on easing prices of food articles and fuel. 'Despite mounting global uncertainty triggered by escalating tensions in the Middle East, Indian markets remained resilient,' Sundar Kewat, Technical and Derivatives Analyst, Ashika Institutional Equity – Ashika Stock Broking part of Ashika Group, said. Foreign Institutional Investors (FIIs) offloaded equities worth Rs 1,263.52 crore on Friday, according to exchange data. In the previous two sessions, the BSE Sensex lost 1,396.54 points or 1.69 per cent, and the Nifty dropped 422.8 points or 1.68 per cent. PTI SUM MR MR This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
&w=3840&q=100)
Business Standard
29 minutes ago
- Business Standard
Markets rebound after two-day slide on DII support, heavyweight gains
Snapping their two-day losing streak, benchmark indices rose on Monday, driven by gains in banking and technology heavyweights, shrugging off the Iran-Israel conflict. Continued buying by domestic institutional investors (DIIs) also helped underpin gains. Most global markets also ended positive, stoking concerns that traders may be undermining the implications of West Asia tensions. The BSE Sensex closed the session at 81,796, up 678 points or 0.8 per cent, while the NSE Nifty rose to 24,947, gaining 228 points or 0.9 per cent. The total market capitalisation of BSE-listed firms increased by ₹3.3 trillion, reaching ₹451 trillion. DIIs were net buyers of equities worth ₹5,781 crore, while foreign institutional investors (FIIs) sold shares worth ₹2,539 crore. DIIs have been net buyers for 20 consecutive sessions, purchasing shares worth ₹94,500 crore. This marks the longest buying spree since the 29-day period of continuous buying that ended on March 19. Despite ongoing attacks between Iran and Israel, crude oil prices stabilised as oil production facilities remained unaffected. The conflict has not yet led to the blockade of the Strait of Hormuz, which handles approximately one-fifth of the world's daily crude shipments. Brent crude was trading below $74, down 1.9 per cent. Gold prices declined by 0.5 per cent, trading at $3,413 per ounce. Analysts expect investors to continue their "buying the dip" approach as long as the conflict does not escalate further and other countries remain uninvolved. "Despite ongoing geopolitical tensions between Israel and Iran, the market moved higher, supported by gains in largecap stocks. Investors maintained their focus on long-term fundamentals amid volatile conditions. Geopolitical developments in West Asia are likely to influence near-term market sentiment, with any signs of de-escalation being closely monitored. Smallcap stocks are expected to underperform in the short term, given their elevated valuations and lack of short-term catalysts," said Vinod Nair, Head of Research at Geojit Financial Services. The market breadth was weak, with 2,151 stocks declining and 1,944 advancing. All but three Sensex stocks gained. Reliance Industries rose 0.76 per cent, and Bharti Airtel gained 1.04 per cent, contributing significantly to Sensex's gains. Tata Motors fell 3.8 per cent — most among Sensex and Nifty components -- after projecting financial year 2026 operating margins of 5 per cent-7 per cent for its luxury unit JLR, below its earlier target of 10 per cent. "The market's resilience amid lingering geopolitical tensions is encouraging. However, participants should remain cautious and not get carried away by a single-day rebound, especially as the index approaches the upper band of its current consolidation range, i.e., the 25,000–25,200 zone. We recommend maintaining a stock-specific trading approach, given the mixed trends across sectors, with a preference for relatively less volatile counters," said Ajit Mishra, SVP of Research at Religare Broking.
The Hindu
2 hours ago
- The Hindu
Lupin, China's SUP ink pact for COPD drug Tiotropium DPI
Lupin has signed a license and supply agreement with Sino Universal Pharmaceuticals (SUP) for commercialisation of chronic obstructive pulmonary disease drug Tiotropium Dry Powder Inhaler, 18 mcg/capsule, in the Chinese market. Under the partnership that will enable Lupin to expand footprint in China, SUP will obtain regulatory approvals for selling Tiotropium DPI in China. Lupin will be the marketing authorisation holder and responsible for manufacturing of the product. Tiotropium DPI is known for its efficacy in improving lung function and quality of life for patients suffering from respiratory conditions. Their partnership comes in backdrop of increasing prevalence of respiratory conditions, Lupin said in a release on Monday. 'This partnership demonstrates our commitment to developing critical products for the treatment of respiratory diseases such as COPD and establishing our leadership in the global respiratory health sector,' Lupin's President of Corporate Development Fabrice Egros said. SUP president Wang Li said 'by bringing more efficient and superior products to market, we aim to make significant breakthroughs in respiratory disease treatment in China, allowing more patients to benefit from international high-quality and innovative products and enjoy respiratory health.' Lupin shares closed with a gain of less than 1% on the BSE at ₹2,010.55 each on Monday.
